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A Biosilification Fusion Protein for a ‘Self-immobilising’
Sarcosine Oxidase Amperometric Enzyme Biosensor
Si Chen[a] and Elizabeth A. H. Hall*[a]
Abstract: Monomeric sarcosine oxidase (mSOx) fusion
with the silaffin peptide, R5, designed previously for easy
protein production in low resource areas, was used in a
biosilification process to form an enzyme layer electrode
biosensor. mSOx is a low activity enzyme (10–20 U/mg)
requiring high amounts of enzyme to obtain an ampero-
metric biosensor signal, in the clinically useful range
<1 mM sarcosine, especially since the Km is >10 mM. An
amperometric biosensor model was fitted to experimental
data to investigate dynamic range. mSOx constructs were
designed with 6H (6×histidine) and R5 (silaffin) peptide
tags and compared with native mSOx. Glutaraldehyde
(GA) cross-linked proteins retained ~5% activity for
mSOx and mSOx-6H and only 0.5% for mSOx-R5. In
contrast R5 catalysed biosilification on (3-mercaptoprop-
yl) trimethoxysilane (MPTMS) and tetramethyl orthosili-
cate (TMOS) particles created a ‘self-immobilisation’
matrix retaining 40% and 76% activity respectively. The
TMOS matrix produced a thick layer (>500 μm) on a
glassy carbon electrode with a mediated current due to
sarcosine in the clinical range for sarcosinemia (0–1 mM).
The mSOx-R5 fusion protein was also used to catalyse
biosilification in the presence of creatinase and creatini-
nase, entrapping all three enzymes. A mediated GC
enzyme linked current was obtained with dynamic range
available for creatinine determination of 0.1–2 mM for an
enzyme layer ~800 nm.
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1 Introduction
Recently there have been fewer innovations in ampero-
metric enzyme biosensors, possibly because the core idea
and technology is robust or perhaps because target
analytes with “block buster” applications like the glucose
biosensor have not been found. Nevertheless, there are
new challenges to overcome with different analytes and in
different measurement environments. For example, in low
and middle income countries (LMICs), where the burden
of chronic non-communicable disease (NCD) is also a
challenge. Mainly cardiovascular diseases, diabetes,
chronic lung disease and cancers, account for 86% of
premature deaths in LMICs [1]. Often there is an absence
of even basic functional diagnostic equipment [2, 3]. In
Mozambique, for example it is reported that only 6% of
facilities could carry out a basic blood glucose analysis
and personal monitoring is not available in general [4].
Despite good intentions to make technology afford-
able, costs are exacerbated by the lack of global Purchas-
ing Power Parity for available health technologies, that
are almost always imported from richer nations. Thus,
local high cost (as a proportion of local income) remains a
barrier to diagnostics in LMICs. A joint statement in May
2016 by WHO, UNIDO, UNCTAD, UNAIDS, UNICEF
and The Global Fund promoted local production of
health technologies to overcome this inequality [5]. The
rationale presented is that by bringing the production
technology to rural areas, it could develop local economy
and improve education, while reducing the cost of
technology to the LMIC. This is a multifaceted problem
that challenges the entire supply and value chain for a
diagnostic. For example, the cost of the enzyme in enzyme
linked biosensors, as a component, can account for 70–
85% of the total cost invested in many LMICs. Thus,
innovation to develop enzymes that can be manufactured
locally, specifically for biosensors is in tune with the
Sustainable Development Goal (SDG) of Good health
and Welbeing as well as having potential to impact SDGs
11 and 8.
We have previously reported a generic approach to
engineer and produce many enzymes in low resource
environments, for diagnostics [6]. This has been success-
fully transferred to laboratories in LMICs and, for
example, nucleic acid amplification studies have been
undertaken in malaria regions and colorimetric and
fluorescent biosensors have been studied [6], but there is
still much scope to simplify designs and further reduce
cost and complexity. Furthermore, although there is also a
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clear need, in chronic disease diagnostics, for locally
produced glucose test strips, many other metabolites also
need to be readily detected and the challenge is to be able
to take a common approach that can provide the
materials for diagnostics for many different biomarkers.
There are numerous examples where new effort is
required to allow low cost diagnostics to be a reality in
LMICs.
In the work reported herein, we will focus on sarcosine
(N-methylglycine), which first gained research interest in
a complex 3-enzyme system, where monomeric sarcosine
oxidase (mSOx) was found to be useful for the enzymatic
determination of creatinine. This could potentially lead to
a point-of-care (POC) biosensor for serum creatinine
level detection. Creatinine is a metabolic byproduct, and
it is an important clinical analyte for the diagnosis and
medical management of renal and muscular dysfunction
[7,8]. However, this creatinine determination requires a
complex three-enzyme system with the sarcosine the
penultimate product linked to mSOx, the final enzyme in
the cascade. The latter catalyses the oxidative demeth-
ylation of sarcosine and forms hydrogen peroxide (which
can be measured).
Although sarcosine is not necessarily the most impor-
tant analyte for LMIC use, it provides a good model for
research since, unlike the glucose enzymes, mSOx shows a
very low activity and will thus be more representative of
the ‘real’ challenge than the robust glucose enzymes.
Furthermore, other health conditions also require direct
information about sarcosine levels; sarcosinemia for
example, occurs due to a metabolic deficiency of folate,
which is required for conversion of sarcosine to glycine. It
can result in sarcosine levels >1000μmole/mmole in urine
[9] and plasma levels of 1 mM have been detected in
infants, where screening can enable early management.
Importantly, sarcosine has also been implicated in the
urine of cancer patients, where significantly elevated
levels have been recorded in some studies, for patients
with prostate cancer (e. g. ~1–3 μM in healthy individuals
compared with 9–15 μM in patients with prostate cancer)
[10]. There is not a consensus on the possible role of
sarcosine, but some studies have suggested that sarcosine
accumulates in the tumor and exhibits a stimulatory effect
on growth in malignant/metastatic prostate cells due to its
conversion to serine and glycine [11–13].
In previous studies [6,14] looking at mSOx production
for resource poor areas, we reported a sarcosine oxidase
fusion enzyme, with mCherry (fluorescent protein) and
the silaffin peptide, R5 (H-SSKKSGSYSGSKGSKRRIL-
OH). R5 is derived from a naturally occurring silaffin
protein that is found in the silica skeleton of the marine
diatom Cylindrotheca fusiformis [15,16]. Inclusion of R5
in the fusion, R52-mCherry-SOx-R5-6H, gave the protein
an affinity to silica and enabled it to be isolated directly
on silica derived from beach sand. This avoided complex
isolation and purification steps. The enzyme remains
immobilised on silica and can be used in various
diagnostic formats including a novel hour-glass like sensor
[6]. These efforts have been directed to optical biosensors,
configured as a two enzyme system with horseradish
peroxidase and a dye, ultrared. Sarcosine levels could be
estimated in the required clinical range for a prostate
cancer diagnostic (<20 μM) and a preliminary test of
urine samples was undertaken [14].
An amperometric biosensor could remove the need
for the peroxidase and indicator dye, and further simplify
the diagnostic, although detection of such low levels is
challenging. Amperometric SOx biosensors have already
been reported, mainly using thick film techniques like
screen printing [17] or with the inclusion of nanoparticles
or porous materials, increasing the surface area for bound
enzyme [18]. Surface area for immobiisation and the
amount of enzyme required is important for this diagnos-
tic because of the low activity on SOx.
For example, glucose oxidase (GOx) and PQQ-
glucose dehydrogenase (GDH) are among the most
robust enzymes discovered. The high activity of GOx and
GDH has made them ideal candidates as the model
enzymes for electrochemical technique development.
GOx has a specific activity ranging from 172–300 U/mg
(μmol/min/mg) [19,20] and for the non-glycosylated
GOx  6H reported in our previous work, the specific
activity was 220 U/mg, whereas the enzymatic activity of
GDH can be as high as 2000 U/mg. These high activities
infer a homogeneous electron transfer rate between the
monolayer enzyme and substrate that lead to measurable
electrode currents. In contrast, SOx (10–20 U/mg) and
other low activity enzymes produce little current for the
same amount of enzyme. As shown by Zhou et al. [21],
large amounts of enzyme are required to get an equiv-
alent signal. If this is achieved by increasing the electrode
surface area, it usually comes with a very high capacitive
(background) current.
So, the challenge is to immobilize sufficient enzyme in
the vicinity of the electrode to generate an amperometric
signal with such a low activity enzyme and be able to
measure in the 0–1 mM range (sarcosinemia) or 0–30 μM
range (prostate cancer). We have previously reported
immobilization of 33 pmole/cm2 of a C-terminal hexa-
histidine engineered glucose oxidase (GOx-C6H), at a
copper complexed NTA electrode, which was able to
produce sufficient current to measure glucose concentra-
tions in the physiological range [22]. In context Zhou
et al. [21] needed 118 nmole/cm2 SOx at an electrode.
They achieved this by producing a high surface area for
immobilisation with a graphene, chitosan and silver nano-
particle (AgNPs) modified glassy carbon electrode. De-
spite this success, the oxidation of sarcosine by SOx was
not reported, only the (reverse) reduction of its co
product, hydrogen peroxide.
The work reported herein targets the sarcosine levels
required in the clinical range for sarcosinemia (nominally
<1 mM) and considers whether the mSOx-R5 fusion
protein provides a self-immobilising protein model that
would give access to amperometric enzyme biosensors for
low activity enzymes like SOx-6H.
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2 Experimental
2.1 Materials
Glutaraldehyde solution 25% (v/v), Bradford Reagent,
sodium chloride, potassium chloride, sarcosine, commer-
cial mSOx, 4-aminoantipyrine, phenol, horseradish
peroxidase, sarcosine, ethanol, horseradish peroxidase
(HRP), sodium hydroxide (NaOH), hydrochloric acid
(HCl), urea, Tetramethyl orthosilicate (TMOS), (3-mer-
captopropyl) trimethoxysilane (MPTMS), ferrocene car-
boxylic acid, potassium chloride, 30% (v/v) hydrogen
peroxide solution, creatininase (E.C. 3.5.2.10), creatinase
(E.C. 3.5.3.3), were purchased from Sigma Aldrich.
Carbon nanotubes were kindly provided by Alphasense
Ltd. Glassy carbon electrode (GCE), silver silver chloride
reference electrode (Ag/AgCl) and platinum counter
electrode were purchased from BASi, Mineral, Chemistry,
Environmental Protection Laboratory Equipment and
Harvard Apparatus Ltd respectively.
2.2 Protein Design and Expression
The original mSOx sequence was ordered from GeneArt
TM Gene Synthesis. The gene was cloned into a pEt24a
plasmid and expression and isolation followed the
procedure described previously [6]. After expression and
purification, C-terminal 6H tagged (mSOx-6H) and C-
terminal R5 tagged mSOx (mSOx-R5), each gave a yield
of 35 mg/L culture. Circular dichroism was carried out in
the Department of Biochemistry, University of Cam-
bridge.
2.3 MPTMS Silica Nanoparticles
MPTMS silica nanoparticles were synthesised by vigo-
rously stirring 80 mL DMSO, 3 mL MPTMS, 2 mL of 5 M
NaOH, and 120 μL H2O2 in a conical flask at room
temperature for 24 h. After 24 h of incubation at room
temperature, the turbidity of the solution increased,
indicating that the particles had been formed. The
synthesised MPTMS silica nanoparticles were collected by
centrifugation at 13,000 rpm for 10 mins. The MPTMS
nanoparticles were then washed 3 times in H2O, by
suspending the collected MPTMS nanoparticles in
1 mLH2O followed by centrifugation at 13,000 rpm for
10 mins.
2.3.1 Immobilisation of Protein-MPTMS on Gold
Electrodes
Protein immobilisation was achieved by vigorously shak-
ing 500 μL protein solution (5 mg/mL) with 100 μL of
MPTMS nanoparticles for 2 h, followed by centrifugation
at 13000 rpm for 10 min to collect the protein immobilised
MPTMS nanoparticles (Protein-MPTMS). Bradford assay
was used to determine protein concentration in the
supernatant. The loosely bonded protein was removed
from the protein-MPTMS composite by washing at least 3
times in 500 μL sodium phosphate buffer (10 mM,
pH 7.5). The washed protein-MPTMS was re-suspended
in 500 μL sodium phosphate buffer (10 mM, pH 7.5) and
the amount of the immobilised protein was determined by
subtracting the amount of the protein determined in the
washouts from the total amount of the protein (5 mg/mL)
that was initially incubated with the MPTMS nano-
particles.
The morphology of MPTMS nanoparticles was exam-
ined using scanning electronic microscopy (SEM), and the
elements were characterised using Energy-dispersive X-
ray spectroscopy (EDX). The hydrodynamic size of
MPTMS nanoparticles were characterised by dynamic
light scattering (DLS); the mean hydrodynamic diameter
for freshly made MPTMS nanoparticle in DMSO was
65�17 nm. After the washing steps, the MPTMS nano-
particles tended to aggregate in the buffer solution; the
hydration shell increased the average hydrodynamic
diameter to 396�68 nm.
100 μL of the Protein-MPTMS suspension solution
was dropped on the gold electrode surface and left at
room temperature for 1 h until the buffer was evaporated.
Different amounts of protein loading were achieved by
diluting the Protein-MPTMS stock solution and the
volume of loading was kept the same.
2.4 mSOx-R5 Catalysed TMOS Nanosphere Synthesis
500 μL of mSOx-R5 (5 mg/mL) in 10 mM sodium
phosphate buffer pH 7.5 was first concentrated to 20 μL
in a Generon Vivaspin 500 concentrating column. A
template for TMOS coating was created with a homoge-
neous CNT suspension, prepared by sonicating CNT
(2 mg) in 1 mL sodium phosphate buffer (10 mM, pH 7.5).
The silica precipitation reaction mixture on the CNT
template consisted of 20 μL of the CNT, 20 μL of the
concentrated mSOx-R5 and various amount 20 μL of
TMOS precursor solution (1 M in 1 mM HCl). The silica
precipitation mix was then vortexed for 5 min. The
mSOx-R5-TMOS silica matrices was washed multiple
times before use until there was no enzyme detected in
the supernatant solution, the final mSOx-R5-TMOS
washed matrix was re-suspended in 1 mL of sodium
phosphate buffer and the concentration of the immobi-
lised mSOx-R5 was determined using Bradford assay to
estimate the binding efficiency.
The surface morphology was visualised using SEM
equipped with an energy-dispersive X-ray spectrometer.
The microscope was operated at 5.00 kV for imaging. The
hydrodynamic size of the mSOx-R5-TMOS matrix was
determined using DLS.
The 20 μL of mSOx-R5-TMOS as described above
was dropped on the GCE surface. The electrode was left
at room temperature for 30mins until the buffer was
evaporated. The functionlised electrode was rinsed with
sodium phosphate buffer (pH 7.5, 10 mM) prior use.
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2.5 Construction of Creatinine Biosensor
20 μL of 25 mg/mL mSOx-R5 in 10 mM sodium
phosphate buffer pH 7.5 was mixed with 20 μL of protein
solution in the same buffer containing 30 mg/mL creatini-
nase and 50 mg/mL creatinase, followed by adding 20 μL
of CNT template suspension solution and (5–20 μL) of
1 M TMOS (in 1 mM HCl). The protein TMOS mixture
was vortexed for 10 min at room temperature for the
formation of mSOx-R5-creatininase-creatinase-TMOS-
CNT matrix. The matrix was then washed three times
using 10 mM sodium phosphate buffer pH 7.5 and
dropped on the GCE for electrochemical experiments.
2.6 Enzyme Assays for Determination of Kinetic
Constants
0–10 μL volumes of sarcosine solution (100 μM), 10 μL of
HRP (0.4 mg/mL) and 10 μL of AR (100 mM) were added
to 5 mg of already prepared mSOx-construct suspended in
water. The final volume in each tube was adjusted to
100 μL with water. After reaction for 20 min at room
temperature (in dark) the fluorescence was measured at
excitation/emission wavelength 530/582 nm. The incre-
ment of fluorescence intensity of sarcosine standard (ISar)
with respect to the blank (I0) was plotted against the
concentration of sarcosine.
A Bradford assay was used to determine total protein
(active and non active). 20 μL of protein solution was
added to 100 μL Bradford reagent (Coomassie Brilliant
Blue in phosphoric acid) in a well plate and absorbance at
595 nm was measured with a UV spectrophotometer and
compared with a standard curve made with BSA.
Electrochemical data were recorded using a PSTAT
10 Autolab potentiostat (Eco-Chemie).
2.7 Theoretical Modelling of the Mediated Amperometric
Biosensor Response
The mathematical model developed previously by us
[23,24] for enzyme film layers in the amperometric
enzyme electrode, was used to compare the current
response of different mSOx biosensor constructs. The
reaction mechanism of the enzyme follows a mediated
Ping-Pong mechanism as refered to later in section 3.2,
where the model is described. The derivation and general
assumptions were as reported previously with the follow-
ing boundary condition created by the second generation
redox mediator, ferrocene carboxylic acid (FCA): reduced
mediator (Medred) was provided to the system in bulk
solution. Normalised reduced mediator concentration
[Medred]=0 at the electrode and [Medred]=1 at the
enzyme layer solution interface. The ‘active’ form of the
mediator for reoxidation of the enzyme is [Medox]=1 
[Medred]. The highest concentration of Medox will be in a
zone next to the electrode. The current (measured at
0.4 V versus Ag/AgCl) arises from the flux of [Medred] at
the electrode.
3 Results and Discussion
3.1 Performance of Peptide Tagged SOx
Monomeric sarcosine oxidase (42 kDa) originates from
Bacillus sp. It is a two-domain protein, with the FAD
making contact with side chains of arginine, lysine,
histidine and the N-terminal end of a helix dipole and
creating an alkaline environment. The isoalloxazine ring
complex (IRC) of FAD is covalently attached to the
Cys315 of the catalytic domain through an 8α-S-cysteinyl
linkage [25,26]. Substrate binding is believed to be located
above the re face of the IRC ring, stabilised by hydrogen
bonds between the substrate carboxylate and the two
basic side chains, Arg52 and Lys348. The adenine ring of
FAD lies at 23.542 Å from the C-terminus, which is
slightly less than the distance from the N terminal
(25.89 Å). There is no indication from this structure that
engineering of the C terminal of the enzyme should
strongly influence the enzyme activity, so to design SOx
constructs suitable for forming a thick enzyme layer on
the electrode to produce a functional amperometric
biosensor, with a low activity enzyme like mSOx, two
basic recombinant enzyme constructs were synthesised,
with C terminal modification of mSOx: mSOx-6H, having
a hexa-histidine peptide tag and mSOx-R5, having a
silaffin tag. In solution, the engineered and native
enzymes had a similar Km but higher kcat was observed for
the engineered enzymes than the native enzyme (Table 1),
suggesting that there had been no detrimental effect on
the active site through C terminal modification. Circular
Dichroism (CD) and structure modelling (supplementary
data Figure S1 and Table S1) are also consistent with
there being no major change in the basic mSOx enzyme
folding.
3.2 Glutaraldehyde Immobilized Enzyme Performance
In preliminary enzyme electrode research, enzyme layers
have often been formed using glutaraldehyde (GA) cross-
linking. Adopting this approach here (Figure 1a) resulted
in considerable loss in enzyme activity. Compared with
the enzyme prior to crosslinking, only ~5% activity
remained for the mSOx-GA and mSOx-6H-GA and only
Fig. 1. Cartoon of enzyme immobilisation for mSOx and its
peptide constructs. (a) glutaraldehyde crosslinking of mSOx,
mSOX-6H and mSOx-R5. (b) MPTMS silanisation with mSOx-
R5 on an Au electrode. (c) TMOS silanisation with mSOx-R5
with a CNT template. (d) as for (c) with creatinase and
creatininase added. Enzyme structures drawn from the RCSB
Protein Data Bank.
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0.5% for mSOx-R5-GA (Table 1). Despite this, using a
second generation mediator like ferrocene dicarboxylic
acid (FCA), SOx enzyme electrodes gave a measurable
current response to sarcosine. However, it can be seen
visually in Figure 2.A1, 2.B1, 2.C1 that the GA cross
linking results in a different electrode performance for
each enzyme. Mediator (FCA) catalysis was confirmed
from the plot of ip=v
1=2 vs. log(scan rate, v) and the kinetic
parameter (kf/a) was extracted, using the theoretical plot
derived by Nicholson and Shain [27] (Figure 2.A3; 2.B3
and 2.C3). This enabled the value of kf (pseudo first order
rate constant) to be obtained from the slope of the plot
and thence the homogeneous second-order rate constant
(ks= =kf/[mSOx]) for FCA in the electrode construct.
Taking into account the deactivation of the enzyme by
GA cross-linking (Table 1), the values for k*s obtained
for ferrocene dicarboxylic acid as mediator with mSOx
and mSOx-6H were an order of magnitude lower than for
glucose oxidase and required at least 20x more enzyme to
achieve a measurable current. Furthermore, since the Km
is circa 16 mM, measurement targeting plasma sarcosine
levels associated with sarcosinemia (<1000 μM) will be at
the low end of the calibration curve, where sensitivity will
be more challenging.
The chronoamperometric data at different sarcosine
concentrations (Figure 2.A2, 2.B2, 2.C2) showed slightly
lower Km than in solution, but consistent with an enzyme
that has retained its structural activity (Table 1). The
electrochemically derived value for k*cat was also of the
same order for the three enzymes.
In thick enzyme layer electrodes, the layer properties
can affect the response and dynamic range of the enzyme.
From the mathematical models developed by us previ-
ously [23, 24], for an enzyme electrode, diffusion and
reaction in the enzyme layer are important in determining
the electrode current and the available dynamic range.
This can be categorised according to the thiele modulus,
�2 = (d2kcat[ET])/(Dmed[Med]b). When �
2 is small, the
response of the sensor is limited by the enzyme kinetics
and when �2 is large it is limited by transport of substrate
and mediator to the enzyme. Taking the kinetic parame-
ters from the Michaelis Menten fit in Figure 2 as input
values, changes affecting �2 can be further explored. The
model is illustrated in Figure 3a, where the mediator FDA
is supplied in its reduced state (Medred) and is oxidised at
the electrode to the ferrocenium ion (Medox). At the
applied oxidising potential [Medred]=0 at the electrode
surface and [Medred]=1 at the enzyme layer/solution
interface.
To understand this in the context of the SOx layers
produced by GA crosslinking, the calibration curves
obtained at the GCE-mSOx-GA, GCE-mSOx-6H-GA
and GCE-mSOx-R5-GA were fitted to the model (Fig-
ure 3b). The layer thickness was estimated from SEM
images and was similar for all these electrodes (354�
51 μm). This is unsurprising since the same mass (but not
activity) of enzyme and GA were used in each case.
Diffusion coefficients for substrate and mediator were not
adjusted for the matrix, but were taken from the
literature. It is noted that the predicted �2is similar and
small in all cases (Table 1), indicating that the response at
the electrode is limited by enzyme kinetics.
Despite adding the same amount of enzyme to each
electrode for GA cross-linking, the amount of active
enzyme was particularly influenced by the R5 peptide
affinity tag, possibly as a result of the number of positively
charged amino acids in the tag (SSKKSGSYSGSKGSKR-
RIL) that are ideal for cross-linking with glutaraldehyde.
As a result, the residual SOx activity might be affected by
the protein engineering; fitting the curves in Figure 3b to
the model predicts 1.29, 0.83 and 0.12 mM enzyme for
GCE-mSOx-GA, GCE-mSOx-6H-GA and GCE-mSOx-
Table 1. Parameters in the enzyme layer model and comparison of enzyme kinetic values for mSOx, mSOx-6H and mSOx-R5.
mSOx mSOx-6H mSOx-R5
In solution GA crosslinked In solution GA crosslinked In solution GA crosslinked
Residual activity (%) 100 5.0�0.4 100 5.6�0.5 100 0.5�0.1
Km (mM) 16.1 13.5 16.3 12.9 16.5 15.3
kcat (s
  1) 9.7 2.67×10  3 12.4 3.56×10  3 16.7 2.81×10  4
k*cat (s
  1) N/A 5.34×10  3 N/A 7.12×10  3 N/A 5.62×10  3
ks (M
  1 s  1) – 0.48� .03×104 – 0.66�0.05×104 – 0.07�0.09×104
k*s (M
  1 s  1) – 9.6�0.6×104 – 11.8�0.7×104 – 15.0�1.6×104
[ET]* (mM) – 1.29 – 0.83 – 0.12
[Med]b (mM) – 1 – 1 – 1
(Dm) (cm
2/s) – 8.5×10  6 – 8.5×10  6 – 8.5×10  6
(Ds) (cm
2/s) – 5.5×10  6 – 5.5×10  6 – 5.5×10  6
dð Þ (μm) – 315 – 328 – 401
A (cm2) – 0.256 – 0.256 – 0.256
�2 – 8.07×10
  5 – 7.48×10  5 – 1.28×10  5
[ET]*, k*cat and k*s are adjusted for active enzyme. Dm and Ds are diffusion coefficients for the mediator and substrate respectively. ET
refers to total enzyme concentration added. A is electrode area, d is enzyme layer thickness. Km and kcat in solution are calculated from
the method in 2.6. The kinetic constants for the immobilized enzyme were obtained by fitting the experimental data to the
electrochemical form of the Michaelis-Menten equation where reaction velocity is replaced by current (Figure 2A2, 1B2 and 1C2
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R5-GA electrodes respectively (see Table 1). Taking the
enzyme layer thickness as the same in each case, the
curves in figure 3b suggest that [ET] interpreted as active
enzyme, dominates the differences in the plots, so that
GCE-mSOx-R5-GA (with circa 10% active enzyme
compared with GCE-mSOx-GA) has the lowest current
response.
This provides an experimental basis to explore the
effects of layer thickness and active enzyme loading
further. Figure 3c shows the predicted variation in current
change with the concentration of sarcosine, modelled for
various values of d, with constant enzyme loading and
enzyme kinetics. These plots show a reduced dynamic
range as the thickness increases. This is accompanied by
an increase in �2 and arises because the active Medox is
generated at the electrode and, for enzyme layers thicker
than the diffusion layer thickness a concentration gradient
extends from [Medox]=1 at the electrode to [Medox]=0 at
distance x’ within the layer. This determines that the
oxidation of the enzyme by Medox is confined to the zone
between 0 < x > x0. Since, the detection range is limited
by the available Medox, the signal may saturate at
artificially low sarcosine concentration. For a low activity
enzyme like SOx, targeting a low dynamic range which is
circa 10% of its Km this reduced range is not problematic.
Indeed, the increase signal resolution within that range is
an advantage. Since �2 also shows a linear dependence on
[ET], enzyme concentration will have a lesser but still
important effect on the usable concentration range of the
sensor, compared with the squared relationship for thick-
ness. For example, for a constant thickness of 200 μm,
Figure 3d suggests that the dynamic range will become
limited ~2 mM SOx in the enzyme layer.
From the trends in Figure 3d and c both active enzyme
[ET] and layer thickness d need to be increased to gain the
required sensitivity at low sarcosine concentrations. To
approach this problem, advantage was taken of the R5
peptide fused SOx, which was used directly to precipitate
Fig. 2. Cyclic voltammograms of A1: 48 nmoles of mSOx-GA, B1: 33 nmoles of mSOx-6H-GA, C1: 72 nmoles of mSOx-R5-GA
modified GCE at various sarcosine concentrations as given in figures A2, B2 and C2 respectively. CV were recorded at scan rate of
50 mV/s. Current response from chronoamperometry of, A2 (21 data sets in duplicate), mSOx-GA, B2 (21 data sets in duplicate),
mSOx-6H-GA and C2 (14 data sets), mSOx-R5-GA at a GC electrode at 0.4 V for various sarcosine concentrations. All data points are
plotted; note that some points overlap and are not resolved. The experimental errors were calculated from the curve fitting. Plots of
kinetic parameter kf/a vs. 1/v for the reaction of FCA at, A3, mSOx-GA; B3, mSOx-6H-GA and C3, mSOx-R5-GA. The data was
obtained from cyclic voltammetry carried out in 10 mM sodium phosphate buffer pH 7.5 containing 50 mM KCl, 300 mM sarcosine.
The values of kf/a were obtained from a working curve derived by Nicholson and Shain [27], and a=nF v/RT. All data were recorded
in 1 mM FCA with various concentrations of sarcosine in 10 mM phosphate buffer containing 50 mM KCl pH 7.5. Ag/AgCl was used as
the reference electrode and platinum was used as the counter electrode.
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an enzyme layer, without requiring additional coupling
reagents and with higher enzyme activity.
3.3 Silica Immobilized Enzyme Performance with R5
Peptide
As reported previously [6], the R5 peptide was designed
for easy isolation of the recombinant protein on silica
isolated from beach sand and then subsequent use of the
enzyme, still attached to the sand. By adding the R5
sequence to the protein construct, the positively charged
residues on the R5 polypeptide (K and R) [28] will
interact with the negative charge of the silica surface.
The use of particulate silica, allows a layer to be
created, supported by the particle. As particle size
increases, the surface area to volume ratio decreases and
thus the immobilisation efficiency per weight of silica
decreases, although packing density and diffusion through
the void volume will also influence the kinetics. To take
this silica (sand) immobilisation process further,
tetramethyl orthosilicate (TMOS) derived particles were
used for initial study rather than beach sand.
The silica obtained from beach sand is a heteroge-
neous size and non-spherical population (figure 4c), so to
partially simulate this with a more controlled sample, two
populations of particles were produced: <1 μm particles
that were approximately spherical, and particles of 300–
800 μm long dimension (Figure 4b) that were seeded onto
CNT templates to make them non-spherical. Unfortu-
nately, enzyme modified TMOS particles <1 μM did not
form a stable layer on the GCE electrode, so (3-
mercaptopropyl) trimethoxysilane (MPTMS) derived par-
ticles (Figure 1b and 4a) were used on a gold electrode.
This formed a stable layer, possibly through coupling to
the gold via the thiol group. Figure 4c shows the hydro-
dynamic radius obtained by dynamic light scattering, for
the different particles, confirming the size difference and
also comparing the TMOS coated particles to the silica
derived from sand that we have used previously for
enzyme immobilization. The SEM images (Figure 4a and
4b) of the resultant particles after deposition confirm the
different shapes and suggest a more densely packed
matrix arises from the small MPTMS particles.
SOx immobilization on the MPTMS particles was
85% efficient, below saturating concentrations, based on
the colorimetric activity assay (see Materials and Meth-
ods) and the resultant enzyme-MPTMS layers gave an
apparent specific activity of 8.6�1.1 U/mg adsorbed
protein. This is 40% of the specific activity for mSOx-R5
in solution, but it isn’t clear whether the loss is due to loss
of activity of the protein (eg thiol coupling between
MPTMS and the protein) or reduced accessibility. Our
previous work has shown that depending on the porosity
or packing of silica particles, not all immobilized enzyme
is accessible to the substrate/solution [6].
In contrast the larger TMOS coated particles (Fig-
ure 1c) achieved similar immobilization efficiency but
recorded 76% of the specific activity in solution. A
Fig. 3. (a) Scheme for the thick layer mediated amperometric
SOx electrode. (b) Experimental data and model fit, for current
response at different sarcosine concentration for mSOx-GA,
mSOx-6H-GA and mSOx-R5-GA. Model predictions for varia-
tion in sensor current with sarcosine concentration for different
values of (c) d (enzyme loading was constant at 0.2 mM) and (d)
ET½ � (thickness was kept at constant at 200 μm) The mediator
concentration was 1 mM.
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suspension of the enzyme modified particles was dropped
onto the electrode and dried to create a film of d=315�
38 μm and 740�63 μm for the MPTMS and TMOS
particles respectively (measured from SEM data). The
cyclic voltammogram for 1 mM FCA produced the
characteristic mediated current in the presence of sarco-
sine (Figure 5a,d). Analysis of ip=v
1=2 vs. log(v) showed
ip=v
1=2 decreasing with scan rate, consistent with a catalyti-
cally controlled reaction as before. This leads to a second
order rate constant k*s for the mediator kinetics derived
from kf, obtained from the slope of the lines in Figure 5c
and 5f, which yielded similar values to those obtained for
the glutaraldehyde cross linked electrodes (see Table 2).
This is expected for the same mediator and enzyme.
The chronoamperometric data for these electrodes, at
different sarcosine concentrations gave calibration curves
(Figure 5b,e) that could be fitted to the Michaelis Menten
relationship to derive the apparent Km and kcat of the
immobilised mSOx-R5. The estimates obtained from
these fits yield an apparent Km for the mSOx-R5 in
MPTMS of 3.9�0.6 mM and 4.2�0.17 mM on TMOS
(Table 2). However, despite the apparently good fit, visual
inspection of these data in Figure 5b,e suggests that the
dynamic range is limited and the data are reaching
‘saturation’ currents. Thus, these data were fitted to the
model for a enzyme layer system (Figure 6) to explore
their performance compared with GCE-mSOx-R5-GA.
The gold-mSOx-R5-MPTMS had a 7-fold increase in
active [ET] (as measured from the activity assay, see
section 2.6) but decrease in thickness, compared with the
GCE-mSOx-R5-GA. The model for gold-mSOx-R5-
MPTMS suggested a decrease in the diffusion coefficient
for the mediator in this matrix (Table 2) would account
for the increase in diffusion limitation, but similar current
response (Figure 6a,b versus Figure 3b). This may be
consistent with the apparently dense structure indicated
from the SEM in figure 4a. In contrast, the electrodes
with the GCE-mSOx-R5-TMOS, have an order of
magnitude increase in active [ET], combined with increase
in layer thickness, compared with GCE-mSOx-R5-GA.
This resulted in a dynamic range limited to 7 mM
sarcosine, but with an increase of 440% in the current
(Figure 6c,d) within the clinical range which would be
used for determination of sarcosine. We conclude there-
fore, that the R5 catalysed biosilification can provide a
useful thick layer immobilisation method for mSOx in an
amperometric electrode.
3.4 Application in a Multienzyme Model
This approach can also be applied to adjusting the limit of
detection and dynamic range for more complex enzyme
systems. For example, as discussed in the introduction,
creatinine can be measured in the following pathway:
In our previous work using cascading enzyme path-
ways [14], we combined mSOx immobilised on silica with
peroxidase immobilised separately, using GA. By co-
immobilising creatininase and creatinase with mSOx (Fig-
ure 1d), it was possible to generate an optical detection
method for creatinine. However, since the R5 tag
catalyses the biosilification of tetramethyl orthosilicate
(TMOS) [29,30], the mSOx-R5 might be able to catalyse
Fig. 4. SEM image of (a) mSOx-R5-MPTMS matrix (b) mSOx-
R5-TMOS matrix. (c) Hydrodynamic size distribution of mSOx-
R5-MPTMS matrix and mSOx-R5-TMOS matrix (10 mM in
sodium phosphate buffer) compared with silica extracted from
beach sand.
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the co-entrapment of other native proteins without addi-
tional protein engineering. It has been reported that
protein activity has been retained with an R5 catalysed
entrapment of silica, but Marner et al. [31] reported that a
simple mixture of R5 with the protein of interest in the
1 :1 molar ratio was not capable of silification.
Nevertheless, to test this multienzyme approach the
GCE-mSOx-R5-TMOS was produced in the presence of
creatininase and creatinase; this produced an enzyme
layer thickness of 145�23–900�38 μm. Figure 7a shows
that the surface morphology of the mSOx-R5-creatini-
nase-creatinase-TMOS is less uniform than the micro-
sphere structure observed at the mSOx-R5-TMOS. This is
probably because the mSOx-R5-creatininase-creatinase-
TMOS has encapsulated 2.75 times more protein and
created a more protein rich structure. Figure 7b shows the
chronoamperometric data in the presence of creatinine
for a layer thickness of. From these data and considering
the background current, the biosensor gives a limit of
detection of 340 μM with dynamic range up to 1430 μM.
However the required range of clinical interest for
sarcosinemia is from 10 to 1000 μM so the higher
concentration response and dynamic range can be
sacrificed to obtain higher sensitivity at lower concen-
tration.
Although this multi-enzyme model has not been
modelled, from the modelling of the layer thickness
discussed earlier for one enzyme, an increase in the
thickness might increase sensitivity and decrease range, so
the layer thickness was increased by increasing the
amount of TMOS in the R5 catalysed biosilification.
Figure 7c and d show the FCA mediated current change
for enzyme layers of 123–783 μm. These layers are stable
with enzyme activity being retained at room temperature
Fig. 5. Cyclic voltammograms of (a) mSOx-R5-MPTMS gold electrode (d) mSOx-R5-TMOS GC electrode containing 1 mM FCA and
0 (black) or 300 mM sarcosine (red). CV were recorded at scan rate of 50 mV/s. Current response from chronoamperometry of (b)
mSOx-R5-MPTMS gold electrode and (e) mSOx-R5-TMOS GC electrode at a GC electrode at 0.4 V for various sarcosine
concentrations. Plots of kinetic parameter kf/a vs. 1/v for the reaction of FCA at (c) mSOx-R5-MPTMS gold electrode and (f) mSOx-
R5-TMOS GC electrode. The data was obtained from cyclic voltammetry carried out in 10 mM sodium phosphate buffer pH 7.5
containing 50 mM KCl, 300 mM sarcosine. The values of kf/a were obtained from a working curve derived by Nicholson and Shain [27],
and a=nF v/RT. Ag/AgCl was used as the reference electrode and platinum was used as the counter electrode.
Table 2. Comparison of enzyme kinetic values for GCE-mSOx-R5-TMOS Gold-mSOx-R5-MPTMS and GCE-mSOx-R5-GA.
GCE-mSOx-R5-TMOS Gold-mSOx-R5-MPTMS GCE-mSOx-R5-GA
d (μm) 740 315 401
k#cat(s
  1) 5.62×10  3 5.62×10  3 5.62×10  3
E*T (mM) 1.12 0.89 0.12
Dmed (cm
2/s) 6.9×10
  6 1.0×10  6 8.5×10  6
A (cm2) 0.233 0.078 0.256
ks (M
  1 s  1) 10.2�0.12×104 3.5�1.1×104 0.07�0.09×104
k*s (M
  1 s  1) 13.4�0.14×104 8.75�1.2×104 15.0�1.6×104
k*s is adjusted for active enzyme. k
#
cat is the input value used in modelling.
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over several weeks (as shown previously [6, 14]). For the
thickest layer, the LOD is reduced to 8 μM, with a
dynamic range to 1700 μM. This has not yet been tested
on clinical samples but it demonstrates a considerable
increase in versatility of the R5 fusion proteins, where a
‘mix and match’ combination might be achieved by
exploiting the biosilification capabilities of the peptide as
well is its ability to adsorb fusion proteins on to silica with
high retention of enzyme activity.
Fig. 6. Fitting the model to experimental data for the current
response of (a) and (b) Au-mSOx-R5-MPTMS and (c) and (d)
GCE-mSOx-R5-TMOS at various sarcosine concentrations. (a)
and (c) sarcosine concentration range: 0 mM–150 mM (b) and (d)
sarcosine concentration range: 0 mM–15 mM. Current response
was obtained from chronoamperometry at 0.4 V in 10 mM
sodium phosphate buffer pH 7.5 containing 50 mM KCl,
1 mMFCA. Ag/AgCl was used as the reference electrode and
platinum was used as the counter electrode.
Fig. 7. (a) SEM of the mSOx-R5-creatininase-creatinase-TMOS
composite (b) Chronoamperometric responses curve of the GCE-
mSOx-R5/creatininase-creatinase electrode (333 μM mSOx-R5)-
TMOS electrode. Applied potential: +0.4 V vs Ag/AgCl; counter
electrode: platinum; supporting electrolyte: 1 mM FCA,10 mM
sodium phosphate buffer, 50 mM KCl pH 7.5. The experimental
errors was calculated from the curve fitting. (c) and (d) (scale
expanded) comparison of current response at the GCE-mSOx-
R5-creatininase-creatinase-TMOS electrode with same enzyme
loading, but different layer thickness, achieved by varying
amounts of TMOS.
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3 Conclusions
In this manuscript we have reported on the further use of
the mSOx-R5 fusion protein in creating enzyme layers of
variable thickness. Previous work [6] has shown the easy
production and isolation of these R5 fusion proteins in a
low resource environment due to their affinity for silica,
allowing non-denaturing irreversible immobilisation of
the protein. Silica is a core low cost abundantly available
material which we have obtained previously from beach
sand. In this work, we show that the R5 catalysed
biosilification can be used to build stable thick enzyme
layers and we have applied this technique to the develop-
ment of a thick layer amperometric enzyme model using
monomeric sarcosine oxidase to measure sarcosine. This
low activity enzyme is a challenging system for an
amperometric biosensor, since not only is its activity only
circa 1% of many of the redox glucose enzymes used in
biosensors, but the targeted clinical range is only 10% of
the enzyme Km. Nevertheless, using a silica matrix for
enzyme immobilisation of the R5 fused mSOx, we are
able to show how the enzyme layer can be manipulated to
obtain a stable thick layer able to produce a measurable
current in the required range. Furthermore, the R5
catalysed biosilification system can be further applied to
multienzyme systems with unexpected success. In this
case, a combination of creatininase and creatinase were
co immobilised with mSOx-R5, allowing an enzyme
electrode to be produced of ~1 mm thick enzyme layer
that responded to creatinine with a LOD of 8 μM, and a
dynamic range to 1700 μM. Importantly, this result shows
that the biosilification only requires one protein to
contain the R5 tag. However, we have previously shown
that without the R5, the immobilisation is not stable [6].
The data reported herein provide a basis to further
expand the manufacturing techniques for use in low
resource areas and to contribute to the challenge of
delivering sustainable diagnostics in these environments.
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